2018
DOI: 10.1016/j.ejogrb.2018.03.056
|View full text |Cite
|
Sign up to set email alerts
|

Myeloid sarcoma as a simulator of advanced ovarian cancer: A case report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…First-line treatment for ovarian MS is total hysterectomy and bilateral salpingo-oophorectomy with systemic induction chemotherapy, as surgical excision does not necessarily delay the spread of the disease ( Ding et al, 2015 ) ( Almond et al, 2017 , Capote et al, 2018 , Peloquin et al, 2013 , Wang et al, 2017 ). There is a paucity of literature and no significant prospective data reporting the survival and prognosis of patients with MS, given its rarity ( Almond et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…First-line treatment for ovarian MS is total hysterectomy and bilateral salpingo-oophorectomy with systemic induction chemotherapy, as surgical excision does not necessarily delay the spread of the disease ( Ding et al, 2015 ) ( Almond et al, 2017 , Capote et al, 2018 , Peloquin et al, 2013 , Wang et al, 2017 ). There is a paucity of literature and no significant prospective data reporting the survival and prognosis of patients with MS, given its rarity ( Almond et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…The most common reason cited for misdiagnoses has been inadequate immunophenotyping of the MS lesion [15]. Immunohistochemical staining is important in the correct diagnosis, as MS lesions express both myeloid and monocytoid antigens including CD45, CD43, and CD15 [16].…”
Section: Discussionmentioning
confidence: 99%
“…There has been scarce literature investigating the survival and prognosis of patients with MS. First-line treatment usually involves systemic induction chemotherapy as surgical excision does not delay spread of disease or improve prognosis [16,17]. There have also been case reports that suggest that a robust inflammatory response following a surgical procedure could worsen MS or lead to a postoperative persistent febrile syndrome [18].…”
Section: Discussionmentioning
confidence: 99%